Biodexa Pharmaceuticals (BDRX) Competitors $5.71 +0.02 (+0.35%) Closing price 03:59 PM EasternExtended Trading$5.50 -0.21 (-3.68%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BDRX vs. FLGC, NXTC, TXMD, LGVN, BFRG, HCWB, BIVI, NBY, GOVX, and IMCCShould you be buying Biodexa Pharmaceuticals stock or one of its competitors? The main competitors of Biodexa Pharmaceuticals include Flora Growth (FLGC), NextCure (NXTC), TherapeuticsMD (TXMD), Longeveron (LGVN), Bullfrog AI (BFRG), HCW Biologics (HCWB), BioVie (BIVI), NovaBay Pharmaceuticals (NBY), GeoVax Labs (GOVX), and IM Cannabis (IMCC). These companies are all part of the "pharmaceutical products" industry. Biodexa Pharmaceuticals vs. Its Competitors Flora Growth NextCure TherapeuticsMD Longeveron Bullfrog AI HCW Biologics BioVie NovaBay Pharmaceuticals GeoVax Labs IM Cannabis Flora Growth (NASDAQ:FLGC) and Biodexa Pharmaceuticals (NASDAQ:BDRX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Does the media refer more to FLGC or BDRX? In the previous week, Flora Growth and Flora Growth both had 2 articles in the media. Flora Growth's average media sentiment score of 0.52 beat Biodexa Pharmaceuticals' score of 0.50 indicating that Flora Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Flora Growth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biodexa Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer FLGC or BDRX? Flora Growth presently has a consensus price target of $93.00, indicating a potential upside of 324.46%. Given Flora Growth's stronger consensus rating and higher probable upside, equities analysts clearly believe Flora Growth is more favorable than Biodexa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Biodexa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation and earnings, FLGC or BDRX? Biodexa Pharmaceuticals has lower revenue, but higher earnings than Flora Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.21-$15.91M-$34.38-0.64Biodexa Pharmaceuticals$470K7.53-$7.32MN/AN/A Which has more risk and volatility, FLGC or BDRX? Flora Growth has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Comparatively, Biodexa Pharmaceuticals has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Do insiders & institutionals believe in FLGC or BDRX? 36.0% of Flora Growth shares are held by institutional investors. Comparatively, 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. 12.6% of Flora Growth shares are held by company insiders. Comparatively, 0.3% of Biodexa Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is FLGC or BDRX more profitable? Biodexa Pharmaceuticals has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. Biodexa Pharmaceuticals' return on equity of 0.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-24.86% -261.57% -48.06% Biodexa Pharmaceuticals N/A N/A N/A SummaryFlora Growth beats Biodexa Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BDRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDRX vs. The Competition Export to ExcelMetricBiodexa PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.53M$3.13B$5.75B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E RatioN/A20.8978.4326.42Price / Sales7.53458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book1.969.9310.916.06Net Income-$7.32M-$53.38M$3.29B$266.28M7 Day Performance4.39%0.05%0.01%-0.76%1 Month Performance-18.19%7.08%7.06%3.83%1 Year PerformanceN/A11.92%50.09%24.39% Biodexa Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDRXBiodexa Pharmaceuticals0.6347 of 5 stars$5.71+0.4%N/AN/A$3.53M$470K0.0020News CoverageShort Interest ↓FLGCFlora Growth2.6069 of 5 stars$22.83+11.6%$93.00+307.4%-41.6%$13.22M$52.37M-0.66280Short Interest ↑NXTCNextCure4.6066 of 5 stars$4.81-4.4%$25.50+430.1%-72.1%$12.89MN/A-0.1990News CoveragePositive NewsShort Interest ↓TXMDTherapeuticsMD0.2304 of 5 stars$1.09-2.3%N/A-38.3%$12.44M$1.76M0.00420Positive NewsGap DownLGVNLongeveron2.636 of 5 stars$0.82-1.5%$7.67+839.5%-60.4%$12.39M$2.07M-0.1320Short Interest ↑BFRGBullfrog AI0.778 of 5 stars$1.21flatN/A-48.9%$12.20M$60K-1.594HCWBHCW Biologics3.233 of 5 stars$5.45-4.8%$35.00+542.8%-71.4%$12.04M$2.57M-0.4040Positive NewsShort Interest ↓Gap DownBIVIBioVie0.3733 of 5 stars$1.58+3.9%N/A-93.7%$11.89MN/A-0.0210High Trading VolumeNBYNovaBay Pharmaceuticals0.498 of 5 stars$2.04+14.6%$0.85-58.3%+453.0%$11.88M$9.78M-0.0430Gap UpGOVXGeoVax Labs2.063 of 5 stars$0.74-0.2%$8.50+1,042.8%-83.5%$11.85M$3.95M-0.3710News CoverageGap UpIMCCIM Cannabis0.1892 of 5 stars$2.26-2.8%N/A-17.1%$11.84M$39.44M-4.18340Negative NewsShort Interest ↑ Related Companies and Tools Related Companies Flora Growth Competitors NextCure Competitors TherapeuticsMD Competitors Longeveron Competitors Bullfrog AI Competitors HCW Biologics Competitors BioVie Competitors NovaBay Pharmaceuticals Competitors GeoVax Labs Competitors IM Cannabis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDRX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals PLC Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDRX Stock Alerts